Status:
ACTIVE_NOT_RECRUITING
The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
6+ years
Brief Summary
Since February 2019 the first hybrid closed-loop insulin pump, the Medtronic MiniMed 670G system, has been offered to people with type 1 diabetes in Belgium. Despite previous studies, the impact of th...
Eligibility Criteria
Inclusion
- patients with type 1 diabetes
- patients aged 6 years or older
- patients starting with hybrid closed-loop therapy (as part of routine clinical practice) in one of the 17 participating centers. Note: the decision about which patient to start, is left to the clinical judgement of the treating health care professional.
- patients who signed informed consent
Exclusion
- patients without type 1 diabetes
- patients under 6 years of age
- patients not starting with hybrid closed-loop therapy in one of the 17 participating centers
- patients who did not sign informed consent
Key Trial Info
Start Date :
March 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
1150 Patients enrolled
Trial Details
Trial ID
NCT04414280
Start Date
March 12 2020
End Date
December 31 2025
Last Update
March 17 2025
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Vlaams-Brabant, Belgium, 3000
2
OLVZ Aalst
Aalst, Belgium, 9300
3
GZA Ziekenhuizen - campus Sint-Vincentius
Antwerp, Belgium, 2018
4
Hôpital d'Arlon
Arlon, Belgium, 6700